Fall in Hematocrit per 1000 Parasites Cleared From Peripheral Blood: A Simple Method for Estimating Drug-Related Fall in Hematocrit After Treatment of Malaria Infections by Gbotosho, Grace O. et al.
American Journal of Therapeutics: 
May/June 2014 - Volume 21 - Issue 3 - p 193-197 
doi: 10.1097/MJT.0b013e31822119d9 
Original Article 
Fall in Hematocrit per 1000 Parasites Cleared 
From Peripheral Blood: A Simple Method for 
Estimating Drug-Related Fall in Hematocrit 
After Treatment of Malaria Infections 
Gbotosho, Grace Olusola PhD1,2; Okuboyejo, 
Titilope MSc1; Happi, Christian Tientcha PhD1,2; 
Sowunmi, Akintunde MD1,2,* 
 
Abstract 
A simple method to estimate antimalarial drug-
related fall in hematocrit (FIH) after treatment of 
Plasmodium falciparum infections in the field is 
described. The method involves numeric estimation 
of the relative difference in hematocrit at baseline 
(pretreatment) and the first 1 or 2 days after 
treatment begun as numerator and the corresponding 
relative difference in parasitemia as the 
denominator, and expressing it per 1000 parasites 
cleared from peripheral blood. Using the method 
showed that FIH/1000 parasites cleared from 
peripheral blood (cpb) at 24 or 48 hours were similar 
in artemether–lumefantrine and artesunate–
amodiaquine-treated children (0.09; 95% confidence 
interval, 0.052–0.138 vs 0.10; 95% confidence 
interval, 0.069–0.139%; P = 0.75) FIH/1000 
parasites cpb in patients with higher parasitemias 
were significantly (P < 0.0001) and five- to 10-fold 
lower than in patients with lower parasitemias 
suggesting conservation of hematocrit or red cells in 
patients with higher parasitemias treated with 
artesunate–amodiaquine or artemether–lumefantrine. 
FIH/1000 parasites cpb were similar in anemic and 
nonanemic children. Estimation of FIH/1000 
parasites cpb is simple, allows estimation of 
relatively conserved hematocrit during treatment, 
and can be used in both observational studies and 
clinical trials involving antimalarial drugs. 
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